Holen Sie sich die Stockscreener-App
8.11
4.02%
-0.34
Handel nachbörslich:
8.27
0.16
+1.97%
Schlusskurs vom Vortag:
$8.45
Offen:
$8.5
24-Stunden-Volumen:
155.67K
Relative Volume:
0.74
Marktkapitalisierung:
$212.56M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-2.9983
EPS:
-2.7049
Netto-Cashflow:
$-40.45M
1W Leistung:
+14.23%
1M Leistung:
-3.57%
6M Leistung:
+16.52%
1J Leistung:
-42.77%
1-Tages-Spanne:
$8.04
$8.65
1-Wochen-Bereich:
$7.04
$8.65
52-Wochen-Spanne:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Vergleichen Sie CVRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
8.11 | 221.48M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
Will CVRx Inc. stock recover faster than marketJuly 2025 Gainers & Smart Swing Trading Alerts - ulpravda.ru
Why CVRx Inc. stock is a must watch in 20252025 Dividend Review & Technical Entry and Exit Tips - ulpravda.ru
Dividend Watch: Can CVRX stock resist market sell offsQuarterly Profit Review & AI Driven Price Forecasts - ulpravda.ru
CVRx: Clinical innovation boosts heart failure care - Traders Union
Aug Spikes: Can CVRX stock beat market expectations this quarterPortfolio Profit Report & Daily Profit Maximizing Tips - moha.gov.vn
CVRx’s Barostim therapy receives Category I CPT codes By Investing.com - Investing.com India
Cvrx announces implementation of new category I CPT codes for Barostim therapy - MarketScreener
CVRx announces implementation of new category I CPT codes for Barostim therapy - TipRanks
CVRx, Inc. Announces Transition to Category I CPT Codes for Barostim Therapy Effective January 1, 2026 - Quiver Quantitative
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy - The Manila Times
New billing codes may support wider use of Barostim heart failure therapy - Stock Titan
CVRx signals gratitude towards healthcare community amid heart failure treatment advancements - Traders Union
Institution Moves: Can CVRX stock resist market sell offs2025 Momentum Check & Long-Term Growth Portfolio Plans - moha.gov.vn
Technical Reactions to CVRX Trends in Macro Strategies - Stock Traders Daily
CVRx, Inc.'s (NASDAQ:CVRX) Popularity With Investors Under Threat As Stock Sinks 26% - simplywall.st
CVRx upgraded by William Blair to outperform - MSN
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
CVRx supports St. Cloud Hospital with Barostim implants - Traders Union
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will CVRX stock reach Wall Street targetsJuly 2025 Recap & Fast Moving Market Watchlists - Bölüm Sonu Canavarı
Why CVRx Inc. stock is favored by pension funds2025 Major Catalysts & Risk Managed Trade Strategies - Улправда
Earnings Report: Will CVRX stock deliver long term returnsJuly 2025 Patterns & Long-Term Capital Growth Strategies - Bollywood Helpline
CVRx marks milestone with 25 Barostim implants at Los Robles - Traders Union
Discipline and Rules-Based Execution in CVRX Response - Stock Traders Daily
Why CVRx Inc. stock remains a top recommendation - Улправда
Is CVRx Inc. stock positioned for long term growthJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - DonanımHaber
What analyst consensus says on CVRX stock2025 Growth vs Value & Accurate Technical Buy Alerts - Улправда
How resilient is CVRX stock in market downturnsJuly 2025 Big Picture & Precise Buy Zone Identification - DonanımHaber
Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Novan (NOVN) and CVRx (CVRX) - The Globe and Mail
Is CVRX stock a buy on dips2025 Price Momentum & AI Powered Trade Plan Recommendations - Улправда
How CVRx Inc. stock reacts to Fed rate cutsWeekly Investment Recap & Fast Moving Stock Trade Plans - Улправда
Will CVRX stock outperform tech sector in 2025Earnings Growth Summary & Real-Time Volume Analysis Alerts - Улправда
CVRx hosts webinar on Barostim coding updates ahead of 2026 - Traders Union
CVRx Earnings Notes - Trefis
CVRx prepares for Jan 2026 Barostim billing update - Traders Union
Behavioral Patterns of CVRX and Institutional Flows - news.stocktradersdaily.com
Would You Still Hold CVRx Stock If It Fell Another 30%? - Trefis
Is CVRx Inc. stock supported by strong fundamentals2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Why CVRX stock could rally in 20252025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Johnson & Johnson's Strategic Adjustment in CVRx Inc Holdings - GuruFocus
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 - Investing.com India
Johnson & Johnson Makes a Bold Move with CVRx Stock Sale! - TipRanks
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 By Investing.com - Investing.com Australia
Jobs Data: Will CVRX stock deliver long term returnsMarket Sentiment Review & Capital Efficient Trading Techniques - BỘ NỘI VỤ
CVRX 8-K & SEC Filings - Yahoo Finance
Will CVRX stock deliver long term returnsJuly 2025 Volume & Low Volatility Stock Recommendations - BỘ NỘI VỤ
CVRx stock slides on preliminary revenue miss - MSN
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
CVRx (CVRX) Gets a Buy from Canaccord Genuity - The Globe and Mail
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvrx Inc-Aktie (CVRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 10% Owner |
Nov 24 '25 |
Sale |
10.06 |
2,200 |
22,132 |
4,047,198 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 21 '25 |
Sale |
10.00 |
500 |
5,000 |
4,049,398 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 12 '25 |
Sale |
10.00 |
1,000 |
10,000 |
4,049,898 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 06 '25 |
Sale |
10.21 |
52,332 |
534,310 |
4,051,098 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 07 '25 |
Sale |
10.00 |
200 |
2,000 |
4,050,898 |
| Nielsen Kirk G. | Director |
May 15 '25 |
Buy |
5.45 |
10,966 |
59,795 |
1,910,134 |
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):